MX348797B - Microorganismos probioticos como agentes activos para mejorar el brillo de la tez de la piel. - Google Patents

Microorganismos probioticos como agentes activos para mejorar el brillo de la tez de la piel.

Info

Publication number
MX348797B
MX348797B MX2012006628A MX2012006628A MX348797B MX 348797 B MX348797 B MX 348797B MX 2012006628 A MX2012006628 A MX 2012006628A MX 2012006628 A MX2012006628 A MX 2012006628A MX 348797 B MX348797 B MX 348797B
Authority
MX
Mexico
Prior art keywords
skin
complexion
radiance
enhancing
active agents
Prior art date
Application number
MX2012006628A
Other languages
English (en)
Other versions
MX2012006628A (es
Inventor
Gueniche Audrey
Castiel Isabelle
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of MX2012006628A publication Critical patent/MX2012006628A/es
Publication of MX348797B publication Critical patent/MX348797B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere al uso de al menos un microorganismo probiótico Lactobacillus paracasei NCC 2461 (ST11), como un agente activo que es útil para tratar el deterioro del brillo de la tez de la piel no relacionado con piel grasosa o piel propensa a ser grasosa, el deterioro siendo una tez de piel borrosa y/u opaca.
MX2012006628A 2009-12-08 2010-12-07 Microorganismos probioticos como agentes activos para mejorar el brillo de la tez de la piel. MX348797B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0958750A FR2953408B1 (fr) 2009-12-08 2009-12-08 Microorganismes probiotiques a titre d'actif pour l'eclat du teint de la peau
US28220809P 2009-12-30 2009-12-30
PCT/IB2010/055629 WO2011070508A1 (en) 2009-12-08 2010-12-07 Probiotic microorganisms as active agents for enhancing the radiance of the skin's complexion

Publications (2)

Publication Number Publication Date
MX2012006628A MX2012006628A (es) 2012-07-10
MX348797B true MX348797B (es) 2017-06-29

Family

ID=42557464

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012006628A MX348797B (es) 2009-12-08 2010-12-07 Microorganismos probioticos como agentes activos para mejorar el brillo de la tez de la piel.

Country Status (12)

Country Link
US (1) US20120301452A1 (es)
EP (2) EP2509580A1 (es)
JP (1) JP2013512946A (es)
KR (1) KR20120133373A (es)
CN (3) CN107595762A (es)
BR (1) BR112012013722A2 (es)
ES (1) ES2639023T3 (es)
FR (1) FR2953408B1 (es)
MX (1) MX348797B (es)
PT (1) PT2332520T (es)
SG (2) SG181512A1 (es)
WO (1) WO2011070508A1 (es)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0516437A (pt) * 2004-10-04 2008-09-02 Oreal E Nestec S A L utilização de uma quantidade eficaz de pelo menos um microorganismo, processo de tratamento cosmético, composição cosmética e/ou dermatológica e composição para absorção oral
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
FR2920304B1 (fr) * 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
FR2920305B1 (fr) * 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2953407B1 (fr) * 2009-12-08 2013-06-14 Oreal Microorganismes probiotiques a titre d'actif contre les alterations du microrelief
CN102078486B (zh) * 2011-01-21 2012-06-20 吉林紫鑫药物研究有限公司 一种祛黄褐斑的药物组合物及其制备方法
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US10940169B2 (en) 2015-11-30 2021-03-09 Joseph E. Kovarik Method for reducing the likelihood of developing cancer in an individual human being
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
FR2973226B1 (fr) 2011-04-01 2013-03-29 Oreal Utilisation de composes (ethoxy-hydroxyphenyl)alkylcetone ou ethoxyhydroxyalkylphenol pour traiter la peau grasse
CA2863568A1 (en) 2012-02-14 2013-08-22 The Procter & Gamble Company Topical use of a skin-commensal prebiotic agent and compositions containing the same
GB201206599D0 (en) * 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
MX2015001751A (es) 2012-08-07 2015-11-13 Topgenix Inc Composicion topica comprendiendo bacterias transformadas que expresan un compuesto de interes.
KR101998210B1 (ko) * 2012-10-31 2019-07-10 (주)아모레퍼시픽 녹차 유산균을 포함하는 피부 각질 제거용 조성물
FR2999930A1 (fr) * 2012-12-21 2014-06-27 Oreal Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
FR2999931A1 (fr) * 2012-12-21 2014-06-27 Oreal Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
US10413577B2 (en) * 2013-02-22 2019-09-17 The Regents Of The University Of California Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life
FR3004349B1 (fr) * 2013-04-15 2015-11-27 Greentech Applications cosmetiques et pharmaceutiques de lactobacillus pentosus
CN103238851A (zh) * 2013-05-15 2013-08-14 百岳特生物科技（上海）有限公司 用于减重的含胶原蛋白的食品组成物
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11529379B2 (en) 2013-12-20 2022-12-20 Seed Health, Inc. Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
US11026982B2 (en) 2015-11-30 2021-06-08 Joseph E. Kovarik Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
US11672835B2 (en) 2013-12-20 2023-06-13 Seed Health, Inc. Method for treating individuals having cancer and who are receiving cancer immunotherapy
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11213552B2 (en) 2015-11-30 2022-01-04 Joseph E. Kovarik Method for treating an individual suffering from a chronic infectious disease and cancer
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11642382B2 (en) 2013-12-20 2023-05-09 Seed Health, Inc. Method for treating an individual suffering from bladder cancer
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
SI3158054T1 (sl) 2014-06-17 2025-06-30 Crown Laboratories, Inc. Genetsko modificirane bakterije in postopki za genetsko modifikacijo bakterij
WO2015195546A1 (en) 2014-06-17 2015-12-23 TopGeniX, Inc. Topical formulations for uv protection
KR101645531B1 (ko) * 2014-10-23 2016-08-04 주식회사 엘지생활건강 게니스테인 및 다이드제인을 함유하는 액정젤 및 이를 포함하는 항노화용 화장료 조성물
DE202015009464U1 (de) 2014-12-04 2017-09-25 Mary Kay Inc. Kosmetikzusammensetzungen
WO2016130983A1 (en) * 2015-02-12 2016-08-18 Fine Kenneth Davin Probiotic deodorant
WO2017147507A1 (en) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Skin probiotic formulation
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
AU2017240064B8 (en) 2016-03-31 2021-11-11 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
EP3436041B1 (en) 2016-03-31 2023-05-24 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
KR101783728B1 (ko) * 2016-11-30 2017-10-10 바이오앤슈티 주식회사 발효 커피 원두를 유효성분으로 포함하는 피부 미백용 조성물
CN121338053A (zh) * 2017-05-08 2026-01-16 莱雅公司 用于调节角蛋白基质微生物群的装置和方法
CN107184732A (zh) * 2017-07-15 2017-09-22 盖文卓 一种用于祛黄褐斑的药物组合物及其制备方法
US20190060216A1 (en) * 2017-08-31 2019-02-28 Muhammed Majeed Anti-pollution compositions containing bacillus coagulans
CN109512710A (zh) 2017-09-18 2019-03-26 玫琳凯有限公司 化妆品组合物及方法
CN108125902A (zh) * 2018-01-08 2018-06-08 北京科拓恒通生物技术股份有限公司 一种益生菌组合物、护肤精华液和面膜及其制备方法
TWI731209B (zh) * 2018-01-09 2021-06-21 柯順議 益生菌組合物及其用途
IT201800003428A1 (it) * 2018-03-12 2019-09-12 Fb Dermo S R L Composizione cosmetica per il trattamento di alterazioni della iperpigmentazione della pelle
KR102140139B1 (ko) * 2018-03-22 2020-07-31 주식회사 세바바이오텍 피부 유래 유산균 및 그 배양물을 포함하는 화장료 조성물
CN109601982A (zh) * 2018-12-14 2019-04-12 华南理工大学 一种具有祛除黄褐斑功能的保健食品及其制备方法与应用
FR3090384B1 (fr) * 2018-12-21 2021-05-28 Lvmh Rech Effet pro-vitaminique d’un extrait d’un microorganisme probiotique
FR3090383B1 (fr) 2018-12-21 2021-05-28 Lvmh Rech Composition comprenant un extrait de Lactobacillus rhamnosus
KR102123022B1 (ko) * 2018-12-31 2020-06-16 코스맥스 주식회사 피부에 효능이 있는 고농도 프로바이오틱스를 포함하는 조성물
US11672742B2 (en) * 2019-01-03 2023-06-13 Surface Deep LLC Deodorant including at least one fruit acid and methods of using the same
CN109864965A (zh) * 2019-03-28 2019-06-11 叶绿芝生物科技（中山）有限公司 一种黄金肌底液组合物
CN109907262A (zh) * 2019-03-28 2019-06-21 广东时代食品与生命健康研究有限公司 一种益生菌组合物
CN109938230A (zh) * 2019-05-07 2019-06-28 江苏华桑食品科技有限公司 一种具有美白功能的饮料的制备方法
CN112245382A (zh) * 2019-07-03 2021-01-22 广东巴松那生物科技有限公司 一种光滑皮肤的磨砂精华液及其制备方法
FR3105922B1 (fr) * 2020-01-08 2022-12-02 Le Rouge Francais Composition cosmétique pour le traitement des lèvres sous forme de solide compact contenant au moins un agent probiotique et au moins un composé choisi parmi l'acide hyaluronique et ses dérivés.
US12102710B2 (en) 2020-06-23 2024-10-01 Crown Laboratories, Inc. Probiotic skin formulations
AU2021396245B2 (en) * 2020-12-09 2025-01-23 Elc Management Llc Ferment from structured water medium and cosmetic composition comprising the same
CN112716850B (zh) * 2021-01-15 2023-07-18 曾万祥 一种具有调节皮肤微生态平衡的组合物及其应用
KR20230140872A (ko) * 2022-03-30 2023-10-10 주식회사 락토메이슨 페디오코쿠스 아시디락티시 lm1013을 유효성분으로 포함하는 자외선에 의한 피부 손상 예방 또는 개선용 조성물
EP4368192A1 (en) 2022-11-09 2024-05-15 Cépages Combination of a lactobacillus strain and a grape extract for use as an anti-ageing agent
EP4623896A1 (en) * 2022-11-23 2025-10-01 Chemyunion Ltda Cosmetic composition for inducing melanin synthesis in an individual or animal; production process; cosmetic method and use
KR20260049280A (ko) * 2023-08-07 2026-04-13 로레알 피부 항-노화 치료를 위한 새로운 조성물
US20250302889A1 (en) * 2024-03-29 2025-10-02 First Day Life, Inc. Ingestible Nutritive Compositions With Prebiotics, Probiotics, and Postbiotics

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3024318A1 (de) 1980-06-27 1982-01-28 Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin Kosmetische mittel
FR2718752B1 (fr) * 1994-04-15 1996-07-12 World Trust Investment Sa Préparations à base de lactosérum fermenté et leurs utilisations.
CN1136429A (zh) * 1995-01-24 1996-11-27 康白 微生态制剂美容霜及其制备方法
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
BRPI0114400B8 (pt) * 2000-10-06 2021-05-25 Nestle Sa uso de bactéria de ácido lático probiótica para equilibrar o sistema imunológico da pele
JP2005526038A (ja) * 2002-02-21 2005-09-02 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 皮膚の光防護のための経口投与可能な組成物
AU2003290130B2 (en) * 2002-12-13 2008-06-05 L'oreal Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration
FR2872047B1 (fr) * 2004-06-23 2007-06-15 Oreal Composition pour peaux sensibles associant cation mineral et probiotique(s)
MXPA06015184A (es) * 2004-06-23 2007-11-22 Nestec Sa Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas.
BRPI0516437A (pt) * 2004-10-04 2008-09-02 Oreal E Nestec S A L utilização de uma quantidade eficaz de pelo menos um microorganismo, processo de tratamento cosmético, composição cosmética e/ou dermatológica e composição para absorção oral
FR2876029B1 (fr) * 2004-10-04 2008-11-14 Oreal Composition cosmetique et/ou dermatologique pour peaux sensibles.
US20060269508A1 (en) 2005-03-29 2006-11-30 Trejo Amy V Means for regulating the cosmetic appearance and/or health of human keratinous tissue
EP1865795A1 (en) * 2005-04-08 2007-12-19 Alimentary Health Limited Methods of use of orally administered probiotic bifidobacteria for human beauty benefits
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
KR101106077B1 (ko) * 2006-08-10 2012-01-18 하우스 웰니스 푸드 코퍼레이션 보습제
CA2697735C (en) * 2007-09-04 2014-02-18 L'oreal Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin
FR2938437B1 (fr) * 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses

Also Published As

Publication number Publication date
CN104188888A (zh) 2014-12-10
SG10201408166QA (en) 2015-02-27
FR2953408B1 (fr) 2013-02-08
EP2509580A1 (en) 2012-10-17
CN107595762A (zh) 2018-01-19
CN102791253A (zh) 2012-11-21
MX2012006628A (es) 2012-07-10
ES2639023T3 (es) 2017-10-25
EP2332520A1 (fr) 2011-06-15
EP2332520B1 (fr) 2017-06-14
JP2013512946A (ja) 2013-04-18
US20120301452A1 (en) 2012-11-29
KR20120133373A (ko) 2012-12-10
PT2332520T (pt) 2017-09-12
WO2011070508A1 (en) 2011-06-16
SG181512A1 (en) 2012-07-30
FR2953408A1 (fr) 2011-06-10
BR112012013722A2 (pt) 2017-04-04

Similar Documents

Publication Publication Date Title
MX348797B (es) Microorganismos probioticos como agentes activos para mejorar el brillo de la tez de la piel.
MX2012006629A (es) Microorganismos probioticos como agentes activos contra cambios en microrelieve de la piel.
MX2010002247A (es) Uso de una combinacion de hesperidina y de un microorganismo para influir en la funcion de barrera de la piel.
MX2019008123A (es) Articulo con estructura soluble de trama fibrosa que comprende agentes activos.
CL2011001811A1 (es) Un metodo para tratar un paciente que ha sufrido un infarto agudo al miocardio que comprende el uso de un agente antifibrotico.
CL2009001874A1 (es) Uso de bacillus subtilis qst713 nrrl b-21661 para formular una composición probiótica para un animal; y composición probiotica de bacillus subtilis qst713 nrrl b-21661.
CL2012000446A1 (es) Uso de una formulación vesicular tópica que comprende uno o más fosfolípidos y uno o más tensoactivos en una razón molar de 1:1 a 25:1 de fosfolípidos a tensoactivos, para el tratamiento de trastornos dermatosos inflamatorios.
CL2011000891A1 (es) Uso de la cepa probiotica lactobacillus reuteri dsm17938 o una composicion nutricional que comprende una cepa bacteriana probiotica lactobacillus reuteri dsm17938 porque sirve para preparar un medicamento o una composicion nutricional util para reducir las alteraciones de sueño y/o mejorar la calidad del sueño o los patrones de sueño en humanos o animales.
MX2013002058A (es) Composicion de tratamiento para cabello.
MX2012009490A (es) Composicion en gel posespumante que comprende un agente contra la irritacion.
CR20130684A (es) Composición limpiadora que comprende un agente gelificante y un tensioactivo empumante
CL2011003065A1 (es) Formulacion vesicular que comprende uno o mas fosfolipidos y uno o mas surfactantes no ionicos, libre de cualquier agente farmaceuticamente activo, util para el tratamiento del dolor asociado con osteoartritis.
WO2009031099A3 (en) Cosmetic use of microorganisms
PE20140591A1 (es) Uso de una composicion que comprende un peptido antimicrobiano como un conservador de alimentos
CL2011002217A1 (es) Suspension acuosa oral que comprende riluzol, un tensioactivo seleccionado de tensioactivos anionicos, tensioactivos no ionicos o una mezcla de ellos, y un agente de suspension seleccionado de arcillas esmectitas, celulosa microcristalina, gomas naturales o sus mezclas; y su uso para tratar esclerosis amiotrofica lateral.
MX2018005796A (es) Reduccion de la sensacion de picazon en la piel.
MX2022005374A (es) Composicion de jabon.
WO2011048554A3 (fr) Association d'un lysat de probiotique et d'un derive c-glycoside
BR112012007798A2 (pt) microcápsulas estáveis e composição para aplicação tópica e método para a preparação de microcápsulas
CL2008002758A1 (es) Composicion que comprende al menos un principio activo laxante y al menos un principio activo antiespumante; uso para el tratamiento del estrenimiento.
UY34985A (es) Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
ES2895910T3 (es) Composiciones multifásicas
WO2011051948A3 (en) Hair care compositions and materials
BR112018001002A2 (pt) composição antimicrobiana com eficácia contra endósporos
ES2723778T3 (es) Terapia dirigida a células madre cancerosas y contra cáncer resistente a fármacos

Legal Events

Date Code Title Description
FG Grant or registration